
Stephen B Hanauer MD
Inflammatory Bowel Disease
Medical Director, Digestive Health Center, Northwestern University Feinberg School of Medicine
Join to view full profile
676 N Saint Clair StSte 650Chicago, IL 60611
Phone+1 312-695-5620
Fax+1 312-695-2310
Dr. Hanauer is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Stephen Hanauer is a gastroenterologist in Chicago, IL and is affiliated with multiple hospitals in the area, including University of Chicago Medical Center and Northwestern Memorial Hospital. He received his medical degree from University of Illinois College of Medicine at Chicago and has been in practice 40 years. He specializes in inflammatory bowel disease and is experienced in general gastroenterology, inflammatory bowel disease, ulcerative colitis, and crohn's disease.
Education & Training
University of ChicagoFellowship, Gastroenterology, 1981 - 1982
University of ChicagoResidency, Internal Medicine, 1977 - 1981
University of Illinois College of MedicineClass of 1977
Certifications & Licensure
FL State Medical License 2024 - Present
IL State Medical License 1978 - 2029
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification PowerChart (Clinical), Cerner Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification Northwestern Meaningful Use Data Warehouse Application for Eligible Providers, Northwestern University, 2013-2017
Clinical Trials
Publications & Presentations
PubMed
- Risk of Extraintestinal Solid Organ Malignancy in Patients with Inflammatory Bowel Disease: A Propensity-Matched Cohort Study.Aakash Desai, Rishi Chowdhary, Himsikhar Khataniar, Francis A Farraye, Raymond K Cross
Digestion. 2026-08-27 - End User Needs and Perspectives for a Digital Opioid Safety Tool in Adolescents and Young Adults With Inflammatory Bowel Disease: A Qualitative Human-Centered Design S...Maria Younan, Amanda Acquaire, Lauren Castro, Deysi Paniagua-Perez, Devyani Dharanipragada
JMIR Formative Research. 2026-07-31 - Corticosteroid-sparing effects of risankizumab versus ustekinumab in patients with moderately to severely active Crohn's disease: post hoc results from the phase 3b SE...Tim Raine, Silvio Danese, Stefan Schreiber, Xiang Gao, Stephen Hanauer
Journal of Crohn's & Colitis. 2026-07-07
Authored Content
- DDW 2025: Perspectives on IBDMay 2025
- The Elephant in the GI SystemJune 2024
- IBD Impressions from DDW 2022May 2022
Press Mentions
Colonoscopies: They Aren’t Fun, but Having One Could Save Your LifeFebruary 20th, 2025
Mindfulness, CBT Combo Improves Quality of Life in Crohn’sOctober 7th, 2024
Subcutaneous Infliximab Beats Placebo for IBD Maintenance TherapySeptember 11th, 2024
Grant Support
- Multi-Site Trial Of Azathioprine Dosing In Crohn DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2004
- Multi-Site Trial Of Azathioprine Dosing In Crohn DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2003
- Anti-Tnfa MAB (Remicad /Infliximab) In Active Crohn'S DINational Center For Research Resources2000–2002
- Phase II Study Of Bxt 51072 In Patients W/ Ulcerative ColitisNational Center For Research Resources1999–2002
- Cdp571 In Steroid Dependent Patients W/ Crohns DiseaseNational Center For Research Resources1999–2002
Committees
- Chair, FDA Gastrointestinal Drugs Advisory Committee 2005 - Present
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: